Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin in New Onset Diabetes After Transplantation (ViNODAT)
2009-014405-14Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in diabetes mellitus (DM) comparing Vildagliptin with Placebo (2 arms). Primary endpoint: Change in 2-hour OGTT glucose. Started Aug 2009; status: completed.
02
Drugs
vildagliptin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on 2009-014405-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014405-14.